Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2016 (2016), Article ID 9639585, 7 pages
http://dx.doi.org/10.1155/2016/9639585
Case Report

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine

1Department of Immunology, Oslo University Hospital, Montebello, 0310 Oslo, Norway
2Department of Clinical Cancer Research, Oslo University Hospital, Montebello, 0310 Oslo, Norway
3Department of Cell Therapy, Oslo University Hospital, Montebello, 0310 Oslo, Norway

Received 11 March 2016; Accepted 13 June 2016

Academic Editor: Jens Sondergaard

Copyright © 2016 Mouldy Sioud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Mouldy Sioud, Marta Nyakas, Stein Sæbøe-Larssen, Anne Mobergslien, Steinar Aamdal, and Gunnar Kvalheim, “Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine,” Case Reports in Medicine, vol. 2016, Article ID 9639585, 7 pages, 2016. doi:10.1155/2016/9639585